| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 14, 2005
Accepted on May 31, 2005
via MAP kinase or PI3 kinase cascade in a human breast cancer cell line
Department of Obstetrics and Gynecology, Division of Nursing, Yamagata University, School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan
* To whom correspondence should be addressed. E-mail: masa{at}med.id.yamagata-u.ac.jp.
In the present study, to examine the dynamic changes in the localization of nuclear ER
induced by growth factors, we used time-lapse confocal microscopy to directly visualized ER
fused with green fluorescent protein (GFP-ER
) in single living cells treated with epidermal growth factor (EGF) or insulin growth factor-1 (IGF-1). We observed that 17
-estradiol (E2) changed the normally diffuse distribution of GFP-ER
throughout the nucleoplasm to a hyperspeckled distribution within 10 min. Both EGF and IGF-1 also changed the nuclear distribution of GFP-ER
, similarly to E2 treatment. However, the time courses of the nuclear redistribution of GFP-ER
induced by EGF or IGF-1 were different from that induced by E2 treatment. In the EGF-treated cells, the GFP-ER
nuclear redistribution was observed at 30 min and reached a maximum at 60 min, while in the IGF-1-treated cells, the GFP-ER
nuclear redistribution was observed at 60 min and reached a maximum at 90 min. The EGF-induced redistribution of GFP-ER
was blocked by pretreatment with a mitogen-activated protein (MAP) kinase cascade inhibitor, PD98059, while the IGF-1-induced redistribution of GFP-ER
was blocked by pretreatment with a phosphatidylinositol (PI) 3 kinase inhibitor, LY294002. Analysis using an AF-2 domain deletion mutant of GFP-ER
showed that the change in the distribution of GFP-ER
was not induced by E2, EGF or IGF-1 treatment. These data suggest that MAP kinase and PI3 kinase cascades are involved in the nuclear redistribution of ER
by EGF and IGF-1, respectively, and that the AF-2 domain of ER
may be needed for the nuclear redistribution of ER
.
This article has been cited by other articles:
![]() |
S. Baron, A. Escande, G. Alberola, K. Bystricky, P. Balaguer, and H. Richard-Foy Estrogen Receptor {alpha} and the Activating Protein-1 Complex Cooperate during Insulin-like Growth Factor-I-induced Transcriptional Activation of the pS2/TFF1 Gene J. Biol. Chem., April 20, 2007; 282(16): 11732 - 11741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |